NDC 58264-0121

D-115

Causticum, Hamamelis Virginiana Root Bark/stem Bark, Iodine, Arsenic Trioxide, Barium Carbonate, Echinacea Angustifolia, Aluminum, Antimony Trisulfide, Strychnos Nux-vomica Seed, Delphinium Staphisagria Seed, Sulfuric Acid, Calcium Sulfide, And Silver Nitrate

D-115 is a Sublingual Solution in the Human Otc Drug category. It is labeled and distributed by Dna Labs, Inc.. The primary component is Causticum; Hamamelis Virginiana Root Bark/stem Bark; Iodine; Arsenic Trioxide; Barium Carbonate; Echinacea Angustifolia; Aluminum; Antimony Trisulfide; Strychnos Nux-vomica Seed; Delphinium Staphisagria Seed; Sulfuric Acid; Calcium Sulfide; Silver Nitrate.

Product ID58264-0121_8ddab621-6611-4983-92fa-6ebec2c3828e
NDC58264-0121
Product TypeHuman Otc Drug
Proprietary NameD-115
Generic NameCausticum, Hamamelis Virginiana Root Bark/stem Bark, Iodine, Arsenic Trioxide, Barium Carbonate, Echinacea Angustifolia, Aluminum, Antimony Trisulfide, Strychnos Nux-vomica Seed, Delphinium Staphisagria Seed, Sulfuric Acid, Calcium Sulfide, And Silver Nitrate
Dosage FormSolution
Route of AdministrationSUBLINGUAL
Marketing Start Date1990-01-01
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameDNA Labs, Inc.
Substance NameCAUSTICUM; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; IODINE; ARSENIC TRIOXIDE; BARIUM CARBONATE; ECHINACEA ANGUSTIFOLIA; ALUMINUM; ANTIMONY TRISULFIDE; STRYCHNOS NUX-VOMICA SEED; DELPHINIUM STAPHISAGRIA SEED; SULFURIC ACID; CALCIUM SULFIDE; SILVER NITRATE
Active Ingredient Strength12 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 58264-0121-1

29.57 mL in 1 BOTTLE, GLASS (58264-0121-1)
Marketing Start Date1990-01-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 58264-0121-1 [58264012101]

D-115 SOLUTION
Marketing CategoryUnapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date1990-01-01
Inactivation Date2020-01-31

Drug Details


© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.